ASGCT news: Chatter about Vinay Prasad, and newborn screening

NEW ORLEANS — Greetings from the house stretch of American Society of Gene and Cell Remedy convention, the place everybody remains to be speaking about Child KJ and nobody desires to speak about Vinay Prasad.

The Vinay Prasad within the room

Final 12 months, a whole bunch of individuals poured in to see Peter Marks, the FDA’s head of biologics, converse at at ASGCT.  The regulator was seen by many advocates, researchers and executives as an ally of their efforts to get uncommon illness remedies authorised, typically regardless of restricted or contradictory proof.

Now, after all, Marks has been fired by the Trump administration. And among the many largest questions going through the gene remedy area is what stance Vinay Prasad, the fiery hematologist and oft-pharma critic who changed him, will take towards such uncommon illness remedies.